Your email has been successfully added to our mailing list.

×
0 0 0.0127696879643389 0.00980683506686495 -0.0239286775631501 -0.0335809806835066 -0.0353640416047548 -0.00729569093610698
Stock impact report

Suffer From Peanut Allergies? A New Treatment Could Reduce Your Everyday Fears [Fortune]

AIMMUNE THERAPEUTICS (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
Company Research Source: Fortune
By Natasha Bach 8:26 AM EST U.S. drug developer Aimmune Therapeutics has made significant strides toward developing a preventive treatment for peanut allergies. The company has created peanut powder capsules intended to help children build a tolerance to the legume, via gradual exposure, reports the Associated Press . Read: Parents Are Saying Peter Rabbit Is an ‘Allergy Bully Aimmune studied close to 500 children ages 4 to 17 with severe peanut allergies, giving the children either the peanut capsules or a dummy powder in increasing quantities over a period of six months. Then, for an additional six months, they continued to take the capsule at the final amount. By the end of the study, 67% of those with the experimental treatment were able to consume the equivalent of about two peanuts, as compared to 4% of those give Show less Read more
Impact Snapshot
Event Time:
AIMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AIMT alerts
Opt-in for
AIMT alerts

from News Quantified
Opt-in for
AIMT alerts

from News Quantified